AcouSort AB (publ) Logo

AcouSort AB (publ)

ACOU.ST

(0.5)
Stock Price

12,10 SEK

-91.85% ROA

-113.66% ROE

-10.52x PER

Market Cap.

202.694.400,00 SEK

0% DER

0% Yield

-417.66% NPM

AcouSort AB (publ) Stock Analysis

AcouSort AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

AcouSort AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

The stock's ROE indicates a negative return (-71.37%) on shareholders' equity, suggesting poor financial performance.

3 ROA

The stock's ROA (-65.64%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (15.88x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-8), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

AcouSort AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

AcouSort AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

AcouSort AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

AcouSort AB (publ) Revenue
Year Revenue Growth
2013 832.547
2014 1.947.117 57.24%
2015 1.575.349 -23.6%
2016 2.722.000 42.13%
2017 2.482.000 -9.67%
2018 1.074.000 -131.1%
2019 1.856.000 42.13%
2020 4.928.000 62.34%
2021 3.007.000 -63.88%
2022 4.963.000 39.41%
2023 4.484.000 -10.68%
2023 10.551.000 57.5%
2024 3.844.000 -174.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

AcouSort AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

AcouSort AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 1.491.496
2014 1.481.753 -0.66%
2015 1.351.071 -9.67%
2016 2.927.000 53.84%
2017 2.239.000 -30.73%
2018 2.634.000 15%
2019 3.377.000 22%
2020 3.826.000 11.74%
2021 3.724.000 -2.74%
2022 6.512.000 42.81%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

AcouSort AB (publ) EBITDA
Year EBITDA Growth
2013 -62.148
2014 121.458 151.17%
2015 -275.201 144.13%
2016 -643.000 57.2%
2017 -6.056.000 89.38%
2018 -8.914.000 32.06%
2019 -9.585.000 7%
2020 -7.638.000 -25.49%
2021 -11.381.000 32.89%
2022 -12.844.000 11.39%
2023 -15.856.000 19%
2023 -16.703.000 5.07%
2024 -18.472.000 9.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

AcouSort AB (publ) Gross Profit
Year Gross Profit Growth
2013 -929.453
2014 35.117 2746.73%
2015 -294.651 111.92%
2016 -643.000 54.18%
2017 1.950.000 132.97%
2018 117.000 -1566.67%
2019 1.079.000 89.16%
2020 3.035.000 64.45%
2021 548.000 -453.83%
2022 2.911.000 81.17%
2023 2.996.000 2.84%
2023 8.389.000 64.29%
2024 -22.832.000 136.74%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

AcouSort AB (publ) Net Profit
Year Net Profit Growth
2013 -62.720
2014 108.009 158.07%
2015 -278.849 138.73%
2016 -830.000 66.4%
2017 -6.072.000 86.33%
2018 -8.960.000 32.23%
2019 -9.683.000 7.47%
2020 -8.220.000 -17.8%
2021 -12.381.000 33.61%
2022 -13.211.000 6.28%
2023 -17.212.000 23.25%
2023 -17.089.000 -0.72%
2024 -18.856.000 9.37%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

AcouSort AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 -1 0%
2018 -1 0%
2019 -1 0%
2020 -1 0%
2021 -1 0%
2022 -1 100%
2023 -1 0%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

AcouSort AB (publ) Free Cashflow
Year Free Cashflow Growth
2013 -3.012.000
2014 -8.597.000 64.96%
2015 -757.000 -1035.67%
2016 -214.000 -253.74%
2017 -9.019.000 97.63%
2018 -7.556.000 -19.36%
2019 -10.430.000 27.56%
2020 -8.628.000 -20.89%
2021 -12.232.000 29.46%
2022 2.954.000 514.08%
2023 -31.772.000 109.3%
2023 -5.421.000 -486.09%
2024 -3.726.000 -45.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

AcouSort AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2013 -3.012.000
2014 -8.597.000 64.96%
2015 -757.000 -1035.67%
2016 -214.000 -253.74%
2017 -8.525.000 97.49%
2018 -7.397.000 -15.25%
2019 -9.843.000 24.85%
2020 -7.035.000 -39.91%
2021 -10.918.000 35.57%
2022 3.965.000 375.36%
2023 -31.559.000 112.56%
2023 -5.279.000 -497.82%
2024 -3.459.000 -52.62%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

AcouSort AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 494.000 100%
2018 159.000 -210.69%
2019 587.000 72.91%
2020 1.593.000 63.15%
2021 1.314.000 -21.23%
2022 1.011.000 -29.97%
2023 213.000 -374.65%
2023 142.000 -50%
2024 267.000 46.82%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

AcouSort AB (publ) Equity
Year Equity Growth
2013 249.470
2014 376.479 33.74%
2015 78.630 -378.8%
2016 9.955.000 99.21%
2017 3.883.000 -156.37%
2018 15.579.000 75.08%
2019 5.922.000 -163.07%
2020 9.592.000 38.26%
2021 33.022.000 70.95%
2022 20.114.000 -64.17%
2023 8.512.000 -136.3%
2023 24.135.000 64.73%
2024 15.297.000 -57.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

AcouSort AB (publ) Assets
Year Assets Growth
2013 2.413.419
2014 920.082 -162.3%
2015 260.703 -252.92%
2016 12.039.000 97.83%
2017 4.947.000 -143.36%
2018 17.439.000 71.63%
2019 8.035.000 -117.04%
2020 13.171.000 38.99%
2021 36.560.000 63.97%
2022 42.656.000 14.29%
2023 16.055.000 -165.69%
2023 34.513.000 53.48%
2024 25.043.000 -37.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

AcouSort AB (publ) Liabilities
Year Liabilities Growth
2013 2.163.949
2014 543.603 -298.08%
2015 182.073 -198.56%
2016 2.084.000 91.26%
2017 1.064.000 -95.86%
2018 1.860.000 42.8%
2019 2.113.000 11.97%
2020 3.579.000 40.96%
2021 3.538.000 -1.16%
2022 22.542.000 84.3%
2023 7.543.000 -198.85%
2023 10.378.000 27.32%
2024 9.746.000 -6.48%

AcouSort AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.31
Net Income per Share
-1.29
Price to Earning Ratio
-10.52x
Price To Sales Ratio
43.86x
POCF Ratio
-12.94
PFCF Ratio
-11.87
Price to Book Ratio
13.28
EV to Sales
40.25
EV Over EBITDA
-8.58
EV to Operating CashFlow
-11.85
EV to FreeCashFlow
-10.89
Earnings Yield
-0.1
FreeCashFlow Yield
-0.08
Market Cap
0,20 Bil.
Enterprise Value
0,19 Bil.
Graham Number
5.46
Graham NetNet
0.58

Income Statement Metrics

Net Income per Share
-1.29
Income Quality
0.82
ROE
-1.14
Return On Assets
-0.77
Return On Capital Employed
-1.45
Net Income per EBT
1
EBT Per Ebit
0.87
Ebit per Revenue
-4.81
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-2.15
Operating Profit Margin
-4.81
Pretax Profit Margin
-4.18
Net Profit Margin
-4.18

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.05
Free CashFlow per Share
-1.14
Capex to Operating CashFlow
-0.09
Capex to Revenue
0.3
Capex to Depreciation
2.65
Return on Invested Capital
-1.12
Return on Tangible Assets
-0.92
Days Sales Outstanding
72.19
Days Payables Outstanding
20.02
Days of Inventory on Hand
55.54
Receivables Turnover
5.06
Payables Turnover
18.24
Inventory Turnover
6.57
Capex per Share
0.09

Balance Sheet

Cash per Share
1,12
Book Value per Share
1,02
Tangible Book Value per Share
0.75
Shareholders Equity per Share
1.02
Interest Debt per Share
0.03
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.77
Current Ratio
2.14
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
15284000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.16
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
2160500
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

AcouSort AB (publ) Dividends
Year Dividends Growth

AcouSort AB (publ) Profile

About AcouSort AB (publ)

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.

CEO
Mr. Torsten Freltoft
Employee
17
Address
Building 406
Lund, 223 81

AcouSort AB (publ) Executives & BODs

AcouSort AB (publ) Executives & BODs
# Name Age
1 Mr. Gunnar Telhammar
Chief Financial Officer
70
2 Prof. Patrik Brundin M.D., Ph.D.
Founder
70
3 Mr. Henrik Johansson
Director of Research & Technology
70
4 Mr. Torsten Freltoft
Chief Executive Officer
70
5 Prof. Thomas Laurell
Founder & Independent Director
70
6 Dr. Stefan Scheding
Founder & Independent Director
70
7 Dr. Hans Lilja
Founder
70

AcouSort AB (publ) Competitors